Shanghai-based humanoid robot developer AgiBot is preparing for a Hong Kong stock market listing, joining a growing wave of Chinese technology firms seeking to raise capital amid booming investor interest in robotics and artificial intelligence.
According to people familiar with the matter, AgiBot has appointed Citic Securities, China International Capital Corporation (CICC), and Morgan Stanley as sponsors for its planned initial public offering (IPO) in Hong Kong.
The company has not officially announced the listing, and representatives of AgiBot and the three financial institutions declined immediate comment.
The Shanghai-based robotics company had already signaled its intention to go public after restructuring from a limited liability company into a joint-stock limited company last year—a key legal requirement for firms planning an IPO in China.
Earlier reports indicated that AgiBot was targeting a valuation between HK$40 billion and HK$50 billion (approximately US$5.1–6.4 billion), reflecting growing investor confidence in China’s rapidly expanding robotics industry.
AgiBot’s planned listing comes as Hong Kong experiences one of its strongest IPO markets in recent years.
According to PwC Hong Kong, companies raised approximately HK$210 billion through IPOs during the first half of 2026, representing a 92% increase compared to the same period last year. The number of new listings also nearly doubled to 87, highlighting renewed investor appetite for technology and innovation-focused companies.
Several major firms are also preparing listings in the city, including fast-fashion giant Shein and optical transceiver manufacturer Zhongji Innolight, whose multi-billion-dollar IPO is expected to rank among Hong Kong’s biggest offerings in years.
Rapid Growth in China’s Humanoid Robot Industry
AgiBot has emerged as one of China’s fastest-growing humanoid robot manufacturers.
Industry research firm Omdia reported that the company shipped 5,168 humanoid robots in 2025, placing it slightly ahead of rival Unitree Robotics, which shipped about 4,200 units, although Unitree has stated its own shipments exceeded 5,500 robots during the year.
The company is now dramatically expanding production capacity.
Company partner and co-president Jiang Qingsong recently said AgiBot aims to ship 40,000 humanoid robots in 2026, representing nearly an eightfold increase over last year’s production.
Expansion Beyond Robotics
AgiBot has also strengthened its presence in China’s capital markets through acquisitions.
Late last year, the company purchased a controlling stake in Shanghai-listed Swancor Advanced Materials for more than 2 billion yuan (about US$295 million).
Although speculation suggested the acquisition could facilitate a backdoor listing, AgiBot denied the transaction was intended for that purpose.
Chinese Robotics Firms Race to Public Markets
AgiBot is part of a broader trend of Chinese robotics companies seeking public investment.
Unitree Robotics recently received regulatory approval to pursue a listing on the Shanghai Stock Exchange. The company reported 1.7 billion yuan in revenue and 591 million yuan in adjusted profit last year and plans to raise around 4.2 billion yuan to expand research, development, and manufacturing.
Meanwhile, IPO applications from Leju Robotics and Deep Robotics have also been accepted by stock exchanges in Shenzhen and Shanghai, underscoring strong investor confidence in China’s robotics sector.
The surge in IPO activity reflects growing global demand for artificial intelligence and intelligent robotics technologies. Chinese manufacturers are investing heavily in humanoid robots for industrial automation, logistics, healthcare, and service applications, positioning the country as one of the world’s leading robotics markets.
If completed, AgiBot’s Hong Kong IPO would further strengthen the city’s position as a preferred fundraising destination for high-growth Chinese technology companies while providing investors with another opportunity to participate in the rapidly evolving AI and robotics industry.
